Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 118

1.

Imaging epidermal growth factor receptor phosphorylation in human colorectal cancer cells and human tissues.

Keese M, Magdeburg RJ, Herzog T, Hasenberg T, Offterdinger M, Pepperkok R, Sturm JW, Bastiaens PI.

J Biol Chem. 2005 Jul 29;280(30):27826-31. Epub 2005 May 20.

2.

Ligand-induced dimer-tetramer transition during the activation of the cell surface epidermal growth factor receptor-A multidimensional microscopy analysis.

Clayton AH, Walker F, Orchard SG, Henderson C, Fuchs D, Rothacker J, Nice EC, Burgess AW.

J Biol Chem. 2005 Aug 26;280(34):30392-9. Epub 2005 Jun 30.

3.

Y-box-binding protein 1 confers EGF independence to human mammary epithelial cells.

Berquin IM, Pang B, Dziubinski ML, Scott LM, Chen YQ, Nolan GP, Ethier SP.

Oncogene. 2005 Apr 28;24(19):3177-86.

PMID:
15735691
4.

Fluorescence lifetime imaging of receptor tyrosine kinase activity in cells.

Wouters FS, Bastiaens PI.

Curr Biol. 1999 Oct 7;9(19):1127-30.

5.
7.

Imaging phosphorylation dynamics of the epidermal growth factor receptor.

Offterdinger M, Georget V, Girod A, Bastiaens PI.

J Biol Chem. 2004 Aug 27;279(35):36972-81. Epub 2004 Jun 23.

8.

Receptor-type protein-tyrosine phosphatase-kappa regulates epidermal growth factor receptor function.

Xu Y, Tan LJ, Grachtchouk V, Voorhees JJ, Fisher GJ.

J Biol Chem. 2005 Dec 30;280(52):42694-700. Epub 2005 Oct 31.

9.

A FRET-based probe for epidermal growth factor receptor bound non-covalently to a pair of synthetic amphipathic helixes.

Itoh RE, Kurokawa K, Fujioka A, Sharma A, Mayer BJ, Matsuda M.

Exp Cell Res. 2005 Jul 1;307(1):142-52. Epub 2005 Apr 7.

PMID:
15922734
10.

Tyrosine phosphorylation of p145met mediated by EGFR and Src is required for serum-independent survival of human bladder carcinoma cells.

Yamamoto N, Mammadova G, Song RX, Fukami Y, Sato K.

J Cell Sci. 2006 Nov 15;119(Pt 22):4623-33. Epub 2006 Oct 24.

12.

Requirement of Tyr-992 and Tyr-1173 in phosphorylation of the epidermal growth factor receptor by ionizing radiation and modulation by SHP2.

Sturla LM, Amorino G, Alexander MS, Mikkelsen RB, Valerie K, Schmidt-Ullrichr RK.

J Biol Chem. 2005 Apr 15;280(15):14597-604. Epub 2005 Feb 11.

13.

Prolactin modulates phosphorylation, signaling and trafficking of epidermal growth factor receptor in human T47D breast cancer cells.

Huang Y, Li X, Jiang J, Frank SJ.

Oncogene. 2006 Dec 7;25(58):7565-76. Epub 2006 Jun 19.

PMID:
16785991
14.

Growth stimulation of non-small cell lung cancer cell lines by antibody against epidermal growth factor receptor promoting formation of ErbB2/ErbB3 heterodimers.

Maegawa M, Takeuchi K, Funakoshi E, Kawasaki K, Nishio K, Shimizu N, Ito F.

Mol Cancer Res. 2007 Apr;5(4):393-401.

15.

Epidermal growth factor receptor in cultured human retinal pigment epithelial cells.

Yan F, Hui YN, Li YJ, Guo CM, Meng H.

Ophthalmologica. 2007;221(4):244-50.

PMID:
17579290
16.

S-Nitrosylation of the epidermal growth factor receptor: a regulatory mechanism of receptor tyrosine kinase activity.

Murillo-Carretero M, Torroglosa A, Castro C, Villalobo A, Estrada C.

Free Radic Biol Med. 2009 Feb 15;46(4):471-9. doi: 10.1016/j.freeradbiomed.2008.10.048. Epub 2008 Nov 11.

PMID:
19056486
17.

Expression of KIT, EGFR, HER-2 and tyrosine phosphorylation in undifferentiated thyroid carcinoma: implication for a new therapeutic approach.

Murakawa T, Tsuda H, Tanimoto T, Tanabe T, Kitahara S, Matsubara O.

Pathol Int. 2005 Dec;55(12):757-65.

PMID:
16287490
18.

Tumor necrosis factor-alpha-stimulated membrane type 1-matrix metalloproteinase production is modulated by epidermal growth factor receptor signaling in human gingival fibroblasts.

Smith PC, Guerrero J, Tobar N, Cáceres M, González MJ, Martínez J.

J Periodontal Res. 2009 Feb;44(1):73-80. doi: 10.1111/j.1600-0765.2007.01081.x.

PMID:
19515020
19.

Ganglioside induces caveolin-1 redistribution and interaction with the epidermal growth factor receptor.

Wang XQ, Sun P, Paller AS.

J Biol Chem. 2002 Dec 6;277(49):47028-34. Epub 2002 Sep 26.

20.

TOB1 is regulated by EGF-dependent HER2 and EGFR signaling, is highly phosphorylated, and indicates poor prognosis in node-negative breast cancer.

Helms MW, Kemming D, Contag CH, Pospisil H, Bartkowiak K, Wang A, Chang SY, Buerger H, Brandt BH.

Cancer Res. 2009 Jun 15;69(12):5049-56. doi: 10.1158/0008-5472.CAN-08-4154. Epub 2009 Jun 2.

Supplemental Content

Support Center